Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Moksnes

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Immunohematology|December 31, 2024
Transient suppression of high-prevalence Kell blood group antigens and concomitant development of a Kell-related antibody that appears to recognize a high-prevalence Kell antigen not previously definedThomas Larsen Titze, Norunn Ulvahaug, Magnus Moksnes, et al.
Journal of Immunology Research|July 3, 2026
Anti-MAG Polyneuropathy: Characterization of the Monoclonal Gammopathy and Clonal B-Cell PopulationGeir Erland Tjønnfjord, Liv Toril N Osnes, Signe Spetalen, et al.
Blood Cancer Journal|December 22, 2025
Optimizing lenalidomide therapy in renal impairment: analysis of renal response in the prospective REMNANT study in transplant-eligible newly diagnosed multiple myelomaFrida Bugge Askeland, Vilhelm Hauge Bugge, Anne-Marie Rasmussen, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Immunohematology|December 31, 2024
Transient suppression of high-prevalence Kell blood group antigens and concomitant development of a Kell-related antibody that appears to recognize a high-prevalence Kell antigen not previously definedThomas Larsen Titze, Norunn Ulvahaug, Magnus Moksnes, et al.
Journal of Immunology Research|July 3, 2026
Anti-MAG Polyneuropathy: Characterization of the Monoclonal Gammopathy and Clonal B-Cell PopulationGeir Erland Tjønnfjord, Liv Toril N Osnes, Signe Spetalen, et al.
Blood Cancer Journal|December 22, 2025
Optimizing lenalidomide therapy in renal impairment: analysis of renal response in the prospective REMNANT study in transplant-eligible newly diagnosed multiple myelomaFrida Bugge Askeland, Vilhelm Hauge Bugge, Anne-Marie Rasmussen, et al.
Pageof 1